Dividends & Buybacks ·
Genenta Science S.p.A. called an Ordinary and Extraordinary Shareholders' Meeting for June 29, 2026
GNTAGenenta Science S.p.A.
Genenta Science S.p.A. called an Ordinary and Extraordinary Shareholders' Meeting for June 29, 2026. Key proposals include approving 2025 financial statements, electing the Board of Directors via two competing slates, and authorizing treasury share transactions. Extraordinary items include a corporate name change to Saentra Forge S.p.A., delegation to the Board to increase share capital or issue convertible bonds, and a proposed reverse stock split to maintain Nasdaq compliance. The company operates in the biotechnology industry, focusing on science-driven healthcare solutions.